申请人:——
公开号:US20030236294A1
公开(公告)日:2003-12-25
Compounds useful for inducing apoptosis in proliferative cells, particularly cancer cells, including but not limited to prostate cancer, leukemia, non-smalll cell lung cancer, colon cancer, CNS cancer, melanoma, ovarian cancer, renal cancer, bladder cancer, lymphoma, and breast cancer. These compounds are particularly useful in the treatment of androgen-independent cancers, including hormone-refractory prostate cancer. Further provided are methods of treating cancer in a subject in need of such treatment using the compounds of the present invention. Further provided are methods for using the compounds of the present invention to treat, inhibit, or delay the onset of cancer in a subject. Further provided are methods of inducing apoptosis in rapidly proliferating cells, particularly, though not necessarily cancer cells, using the compounds of the present invention.
用于诱导增殖细胞凋亡的化合物,特别是癌细胞,包括但不限于前列腺癌、白血病、非小细胞肺癌、结肠癌、中枢神经系统癌、黑色素瘤、卵巢癌、肾癌、膀胱癌、淋巴瘤和乳腺癌。这些化合物在治疗雄激素非依赖性癌症特别有效,包括激素难治性前列腺癌。还提供了使用本发明化合物治疗患有癌症的受试者的方法。此外,还提供了使用本发明化合物治疗、抑制或延迟受试者癌症发生的方法。此外,还提供了使用本发明化合物诱导快速增殖细胞凋亡的方法,特别是虽然不一定是癌细胞。